Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Pramipexole induced psychosis in a patient with restless legs syndrome.

Signorelli MS, Battaglia E, Costanzo MC, Cannavò D.

BMJ Case Rep. 2013 Sep 18;2013. pii: bcr2013009716. doi: 10.1136/bcr-2013-009716.

2.

An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.

Stoner SC, Dahmen MM, Makos M, Lea JW, Carver LJ, Rasu RS.

Ann Pharmacother. 2009 Sep;43(9):1426-32. doi: 10.1345/aph.1M183. Epub 2009 Aug 18.

PMID:
19690226
3.

Recurrence of cluster headache with pramipexole.

Ossemann M.

Acta Neurol Belg. 2010 Sep;110(3):279-80.

PMID:
21114140
4.

Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.

Bayard S, Langenier MC, Dauvilliers Y.

Sleep. 2013 Oct 1;36(10):1501-7. doi: 10.5665/sleep.3044.

5.

Compulsive habits in restless legs syndrome patients under dopaminergic treatment.

Pourcher E, RĂ©millard S, Cohen H.

J Neurol Sci. 2010 Mar 15;290(1-2):52-6. doi: 10.1016/j.jns.2009.11.010. Epub 2009 Dec 6.

PMID:
19969309
6.

Comparison of pregabalin with pramipexole for restless legs syndrome.

Allen RP, Chen C, Garcia-Borreguero D, Polo O, DuBrava S, Miceli J, Knapp L, Winkelman JW.

N Engl J Med. 2014 Feb 13;370(7):621-31. doi: 10.1056/NEJMoa1303646.

7.

Clinical experience with pramipexole in the treatment of restless legs syndrome.

Merlino G, Serafini A, Robiony F, Valente M, Gigli GL.

Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):225-35. doi: 10.1517/17425255.4.2.225. Review.

PMID:
18248314
8.

Efficacy, safety and dose-response of pramipexole in Japanese patients with primary restless legs syndrome: randomized trial.

Inoue Y, Kuroda K, Hirata K, Uchimura N, Kagimura T, Shimizu T.

Neuropsychobiology. 2011;63(1):35-42. doi: 10.1159/000322289. Epub 2010 Nov 9.

PMID:
21063131
9.

Long-term use of pramipexole in the management of restless legs syndrome.

Lipford MC, Silber MH.

Sleep Med. 2012 Dec;13(10):1280-5. doi: 10.1016/j.sleep.2012.08.004. Epub 2012 Oct 1.

PMID:
23036265
10.

Restless legs syndrome: clinical presentation diagnosis and treatment.

Wijemanne S, Jankovic J.

Sleep Med. 2015 Jun;16(6):678-90. doi: 10.1016/j.sleep.2015.03.002. Epub 2015 Mar 10. Review.

PMID:
25979181
11.

Pramipexole in the treatment of restless legs syndrome: a follow-up study.

Montplaisir J, Denesle R, Petit D.

Eur J Neurol. 2000 May;7 Suppl 1:27-31.

PMID:
11054156
12.

Pramipexole: in restless legs syndrome.

McCormack PL, Siddiqui MA.

CNS Drugs. 2007;21(5):429-37; discussion 438-40. Review.

PMID:
17447832
13.

Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.

Trenkwalder C, Stiasny-Kolster K, Kupsch A, Oertel WH, Koester J, Reess J.

Mov Disord. 2006 Sep;21(9):1404-10.

PMID:
16755554
14.

Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin.

Lee CS, Lee SD, Kang SH, Park HY, Yoon IY.

Eur J Neurol. 2014 Feb;21(2):260-6. doi: 10.1111/ene.12286. Epub 2013 Nov 23.

PMID:
24267148
15.

Long-term open-label study of pramipexole in patients with primary restless legs syndrome.

Inoue Y, Kuroda K, Hirata K, Uchimura N, Kagimura T, Shimizu T.

J Neurol Sci. 2010 Jul 15;294(1-2):62-6. doi: 10.1016/j.jns.2010.04.003. Epub 2010 May 7.

PMID:
20451927
16.

A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.

Jama L, Hirvonen K, Partinen M, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.

Sleep Med. 2009 Jun;10(6):630-6. doi: 10.1016/j.sleep.2008.05.014. Epub 2009 Jan 25.

PMID:
19171500
17.

Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.

Inoue Y, Hirata K, Kuroda K, Fujita M, Shimizu T, Emura N, Uchimura N, Kagimura T, Sha K, Nozawa T.

Sleep Med. 2010 Jan;11(1):11-6. doi: 10.1016/j.sleep.2009.03.009. Epub 2009 Dec 4.

PMID:
19962941
18.

Sternberg working memory performance following treatment with pramipexole in patients with moderate-to-severe restless legs syndrome.

Jung KY, Kim SM, Song JY, Lee BU, Lee C, Lee SK, Koo YS, Cho YW, Choi JW, Kim KH.

Sleep Med. 2015 Jun;16(6):703-8. doi: 10.1016/j.sleep.2014.10.025. Epub 2015 Feb 27.

PMID:
25934537
19.

Newer dopamine agonists in the treatment of restless legs syndrome.

Weimerskirch PR, Ernst ME.

Ann Pharmacother. 2001 May;35(5):627-30. Review.

PMID:
11346069
20.

Pramipexole (Mirapex) for restless legs syndrome.

[No authors listed]

Med Lett Drugs Ther. 2007 Mar 26;49(1257):26-8. No abstract available.

PMID:
17375031

Supplemental Content

Support Center